Hypertension in pregnancy a manifestation of the insulin resistance syndrome?

Hypertension

Volumn 37, Issue 2 I, 2001, Pages 232-239

  Solomon, Caren G ^a   Seely, Ellen W ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Gestational; Hypertension; Insulin resistance; Preeclampsia; Pregnancy

Indexed keywords

INSULIN; LEPTIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; TUMOR NECROSIS FACTOR ALPHA;

DISEASE ASSOCIATION; DISEASE PREDISPOSITION; ESSENTIAL HYPERTENSION; FEMALE; GLUCOSE INTOLERANCE; HUMAN; HYPERINSULINEMIA; HYPERLIPIDEMIA; INSULIN RESISTANCE; MATERNAL HYPERTENSION; METABOLIC DISORDER; OBESITY; OVARY POLYCYSTIC DISEASE; PATHOGENESIS; PREECLAMPSIA; PREGNANCY COMPLICATION; PREGNANCY DIABETES MELLITUS; PRIORITY JOURNAL; SHORT SURVEY; BLOOD; HYPERTENSION; PREGNANCY; REVIEW; SYNDROME;

FEMALE; HUMANS; HYPERTENSION; INSULIN RESISTANCE; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; SYNDROME;

EID: 0035095748     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.37.2.232     Document Type: Short Survey

References (88)

1. Banting lecture 1958: Role of insulin resistance in human disease
2. Insulin resistance in essential hypertension
3. Peripheral utilization of glucose in pregnancy. II: Preeclampsia
4. Hypertension in pregnancy: Clinical-pathological correlations and remote prognosis
5. Urinary dipstick protein: A poor predictor of absent or severe proteinuria
6. Insulin secretion and insulin resistance in pregnancy and GDM: Implications for diagnosis and management
7. The 24-hour excursion and diurnal rhythm of glucose, insulin, and C-peptide in normal pregnancy
8. Carbohydrate metabolism during pregnancy in control subjects and in women with gestational diabetes
9. Insulin sensitivity and beta-cell responsiveness to glucose during late pregnancy in lean and moderately obese women with normal glucose tolerance or mild gestational diabetes
10. Endocrine regulation of metabolic homeostasis during pregnancy
11. Endocrine disorders in pregnancy
12. Effect of insulin and glucose infusions on sympathetic nervous system activity in normal man
13. Hypertension and associated metabolic abnormalities: The role of insulin resistance and the sympathoadrenal system
14. The effect of insulin in renal handling of sodium, calcium, potassium, and phosphate in man
15. Insulin resistance is associated with high sodium-lithium countertransport in essential hypertension
16. The emerging concept of vascular remodeling
17. Insulin action during pregnancy: Studies with the euglycemic clamp technique
18. Defects in insulin secretion and action in women with a history of gestational diabetes
19. Factors influencing neonatal morbidity in gestational diabetic pregnancy
20. Pre-eclampsia in diabetic pregnancies
21. Does gestational diabetes represent an obstetrical risk factor?
22. Maternal characteristics, neonatal outcome, and the time of diagnosis of gestational diabetes
23. Hypertension and pre-eclampsia in women with gestational glucose intolerance
24. The relationship between abnormal glucose tolerance and hypertensive disorders of pregnancy in healthy nulliparous women
25. Pregnancy complications among diabetic women: Review 1965-1985
26. A population based study of maternal and perinatal outcomes in patients with gestational diabetes
27. Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome
28. The course and outcome of pregnancy after electrocautery in women with polycystic ovarian syndrome: The influence of body weight
29. Pregnancy in infertile PCOD patients: Complications and outcome
30. Glucose intolerance as a predictor of hypertension in pregnancy
31. Higher cholesterol and insulin levels are associated with increased risk for pregnancy-induced hypertension
32. A multivariate analysis of risk factors for preeclampsia
33. Insulin resistance and increased body mass index in women developing hypertension in pregnancy
34. High body mass index and hypercholesterolemia: Risk of hypertensive disorders of pregnancy
35. Proportional weight gain and complications of pregnancy, labor, and delivery in healthy women of normal prepregnant stature
36. Comparison of plasminogen activator inhibitor-1 concentration in insulin-resistant versus insulin-sensitive healthy women
37. Relationship between insulin sensitivity and plasma leptin concentration in lean and obese men
38. Plasma levels of the soluble fraction of tumor necrosis factor receptor 2 and insulin resistance
39. Glucose clamp technique: A method for quantifying insulin secretion and resistance
40. Glycosylated hemoglobin and hypertension arising in pregnancy
41. Impact of increasing carbohydrate intolerance on maternal-fetal outcomes in 3637 women without gestational diabetes: The Toronto Trihospital Gestational Project
42. Insulin response to oral glucose in patients with preeclampsia
43. An association between hyperinsulinemia and hypertension during the third trimester of pregnancy
44. Hyperinsulinemia in glucose-tolerant women with preeclampsia: A controlled study
45. Serum lipoproteins, insulin, and urinary prostanoids metabolites in normal and hypertensive pregnant women
46. Glucose intolerance in women with preeclampsia
47. Evidence of a state of increased insulin resistance in preeclampsia
48. Gestational hypertension but not pre-eclampsia is associated with insulin resistance syndrome characteristics
49. Insulin sensitivity in pre-eclampsia
50. Hyperinsulinemia and insulin resistance are associated with pre-eclampsia in African-Americans
51. Resistance to insulin-mediated glucose uptake and hyperinsulinemia in women who had hyperinsulinemia in women who had preeclampsia during pregnancy
52. Hyperinsulinemia 17 years after preeclamptic first pregnancy
53. The hyperlipidemia of pregnancy in normal and complicated pregnancies
54. Potential pathogenic roles of aberrant lipoprotein and fatty acid metabolism in pre-eclampsia
55. Fasting serum triglycerides, free fatty acids, and malondialdehyde are increased in preeclampsia, are positively correlated, and decrease within 48 hours post partum
56. Changes in concentrations of lipoprotein (a) and other lipids and lipoproteins in pregnancies complicated by pregnancy-induced hypertension or intrauterine growth retardation
57. Serum lipids in early pregnancy and risk of pre-eclampsia
58. Fasting serum flee fatty acids and triglycerides are increased before 20 weeks of gestation in women who later develop preeclampsia
59. Clinical and biochemical evidence of endothelial cell dysfunction in the pregnancy syndrome preeclampsia
60. Hyperinsulinemia, hyperglycemia, and impaired hemostasis: The Framingham Offspring Study
61. Coagulation and fibrinolysis changes in normal pregnancy: Increased levels of procoagulants and reduced levels of inhibitors during pregnancy induce a hypercoagulable state combined with reactive fibrinolysis
62. Thrombomodulin, plasminogen activator inhibitor Type I (PAI-I) and fibronectin as biomarkers of endothelial damage in preeclampsia and eclampsia
63. Abnormal expression of type 1 plasminogen activator and tissue factor in severe preeclampsia
64. The metabolic significance of leptin in humans: Gender-based differences in relationship to adiposity, insulin sensitivity and energy expenditure
65. Physiological insulinemia acutely modulates plasma leptin
66. Leptin levels in pregnancy: Marker for fat accumulation and mobilization?
67. Maternal plasma leptin is increased in preeclampsia and positively correlates with fetal cord concentration
68. Augmented placental production of leptin in preeclampsia: Possible involvement of placental hypoxia
69. Plasma leptin levels are associated with abnormal fibrinolysis in men and postmenopausal women
70. Serum levels of tumor necrosis factor-alpha are increased in obese patients with noninsulin-dependent diabetes mellitus
71. Tumor necrosis factor during pregnancy and at the onset of labor and spontaneous abortion
72. Tumor necrosis factor-alpha is elevated in plasma and amniotic fluid of patients with severe preeclampsia
73. Interleukin-6, tumour necrosis factor and soluble tumour factor receptors in women with pre-eclampsia
74. Interleukin-1, interleukin-6 and tumor necrosis factor at delivery in preeclamptic disorders
75. Maternal second trimester serum necrosis factor-alpha-soluble receptor p55 (sTNFp55) and subsequent risk of preeclampsia
76. Increased adipose tissue expression of tumour necrosis factor- alpha in human obesity and insulin resistance
77. Lipoprotein lipase suppression in 3T3-LI cells by an endotoxin-induced mediator from exudate cells
78. A prospective study of pregravid determinants of gestational diabetes mellitus
79. Gestational diabetes mellitus
80. The effect of leisure time physical activity on the risk of pre-eclampsia and gestational hypertension
81. Dietary fiber, glycemic load, and risk of non-insulin-dependent diabetes mellitus in women
82. Cardiovascular sequelae of toxemia of pregnancy
83. Long-term effect of preeclampsia on blood pressure
84. Risk of myocardial infarction in young women
85. Death from ischemic heart disease in women with a history of hypertension in pregnancy
86. Hypertension in pregnancy: A potential window into long-term cardiovascular risk in women